Crescent Biopharma (CBIO) Other Gross PP&E Adjustments (2016 - 2025)
Crescent Biopharma (CBIO) has disclosed Other Gross PP&E Adjustments for 11 consecutive years, with -$1.5 million as the latest value for Q4 2025.
- On a quarterly basis, Other Gross PP&E Adjustments changed N/A to -$1.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$1.5 million, a N/A change, with the full-year FY2025 number at -$1.5 million, changed N/A from a year prior.
- Other Gross PP&E Adjustments was -$1.5 million for Q4 2025 at Crescent Biopharma, up from -$1.6 million in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of $1.4 million in Q1 2023 to a low of -$1.6 million in Q2 2025.
- A 5-year average of $35203.6 and a median of $345072.0 in 2021 define the central range for Other Gross PP&E Adjustments.
- Peak YoY movement for Other Gross PP&E Adjustments: surged 647.49% in 2021, then plummeted 246.39% in 2024.
- Crescent Biopharma's Other Gross PP&E Adjustments stood at $815945.0 in 2021, then skyrocketed by 68.91% to $1.4 million in 2022, then tumbled by 187.58% to -$1.2 million in 2023, then surged by 60.75% to -$473770.0 in 2024, then crashed by 210.07% to -$1.5 million in 2025.
- Per Business Quant, the three most recent readings for CBIO's Other Gross PP&E Adjustments are -$1.5 million (Q4 2025), -$1.6 million (Q3 2025), and -$1.6 million (Q2 2025).